Modalities for Imaging of Prostate Cancer
Prostate cancer is the second most common cause of cancer deaths among males in the United States. Prostate screening by digital rectal examination and prostate-specific antigen has shifted the diagnosis of prostate cancer to lower grade, organ confined disease, adding to overdetection and overtreat...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2009/818065 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832564201955000320 |
---|---|
author | A. H. Hou D. Swanson A. B. Barqawi |
author_facet | A. H. Hou D. Swanson A. B. Barqawi |
author_sort | A. H. Hou |
collection | DOAJ |
description | Prostate cancer is the second most common cause of cancer deaths among males in the United States. Prostate screening by digital rectal examination and prostate-specific
antigen has shifted the diagnosis of prostate cancer to lower grade, organ confined
disease, adding to overdetection and overtreatment of prostate cancer. The new challenge
is in differentiating clinically relevant tumors from ones that may otherwise never have
become evident if not for screening. The rapid evolution of imaging modalities and the
synthesis of anatomic, functional, and molecular data allow for improved detection and
characterization of prostate cancer. However, the appropriate use of imaging is difficult
to define, as many controversial studies regarding each of the modalities and their utilities
can be found in the literature. Clinical practice patterns have been slow to adopt many of
these advances as a result. This review discusses the more established imaging
techniques, including Ultrasonography, Magnetic Resonance Imaging, MR Spectroscopy,
Computed Tomography, and Positron Emission Tomography. We also review several
promising techniques on the horizon, including Dynamic Contrast-Enhanced MRI,
Diffuse-Weighted Imaging, Superparamagnetic Nanoparticles, and Radionuclide
Scintigraphy. |
format | Article |
id | doaj-art-6f9080b11c2c439a8c613bce9e7e2b7d |
institution | Kabale University |
issn | 1687-6369 1687-6377 |
language | English |
publishDate | 2009-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Urology |
spelling | doaj-art-6f9080b11c2c439a8c613bce9e7e2b7d2025-02-03T01:11:32ZengWileyAdvances in Urology1687-63691687-63772009-01-01200910.1155/2009/818065818065Modalities for Imaging of Prostate CancerA. H. Hou0D. Swanson1A. B. Barqawi2Division of Urology, University of Colorado Health Sciences Center, UCDSOM, MS C-319, Academic Office One Bldg., 12631 East 17th Ave., Room L15-5602, Aurora, CO 80045, USADivision of Urology, University of Colorado Health Sciences Center, UCDSOM, MS C-319, Academic Office One Bldg., 12631 East 17th Ave., Room L15-5602, Aurora, CO 80045, USADivision of Urology, University of Colorado Health Sciences Center, UCDSOM, MS C-319, Academic Office One Bldg., 12631 East 17th Ave., Room L15-5602, Aurora, CO 80045, USAProstate cancer is the second most common cause of cancer deaths among males in the United States. Prostate screening by digital rectal examination and prostate-specific antigen has shifted the diagnosis of prostate cancer to lower grade, organ confined disease, adding to overdetection and overtreatment of prostate cancer. The new challenge is in differentiating clinically relevant tumors from ones that may otherwise never have become evident if not for screening. The rapid evolution of imaging modalities and the synthesis of anatomic, functional, and molecular data allow for improved detection and characterization of prostate cancer. However, the appropriate use of imaging is difficult to define, as many controversial studies regarding each of the modalities and their utilities can be found in the literature. Clinical practice patterns have been slow to adopt many of these advances as a result. This review discusses the more established imaging techniques, including Ultrasonography, Magnetic Resonance Imaging, MR Spectroscopy, Computed Tomography, and Positron Emission Tomography. We also review several promising techniques on the horizon, including Dynamic Contrast-Enhanced MRI, Diffuse-Weighted Imaging, Superparamagnetic Nanoparticles, and Radionuclide Scintigraphy.http://dx.doi.org/10.1155/2009/818065 |
spellingShingle | A. H. Hou D. Swanson A. B. Barqawi Modalities for Imaging of Prostate Cancer Advances in Urology |
title | Modalities for Imaging of Prostate Cancer |
title_full | Modalities for Imaging of Prostate Cancer |
title_fullStr | Modalities for Imaging of Prostate Cancer |
title_full_unstemmed | Modalities for Imaging of Prostate Cancer |
title_short | Modalities for Imaging of Prostate Cancer |
title_sort | modalities for imaging of prostate cancer |
url | http://dx.doi.org/10.1155/2009/818065 |
work_keys_str_mv | AT ahhou modalitiesforimagingofprostatecancer AT dswanson modalitiesforimagingofprostatecancer AT abbarqawi modalitiesforimagingofprostatecancer |